Epidemiology of meningococcal disease in Denmark 1974-1999: Contribution of the laboratory surveillance system

Epidemiology and Infection

Volumn 133, Issue 2, 2005, Pages 205-215

  Lind, I ^a   Berthelsen, L ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIUM ANTIBODY; CIPROFLOXACIN; PENICILLIN G; RIFAMPICIN; SULFAMETHOXAZOLE; SULFONAMIDE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLINICAL LABORATORY; COUNTER IMMUNOELECTROPHORESIS; DENMARK; DNA DETERMINATION; EPIDEMIC; HEALTH SURVEY; HUMAN; IMMUNOASSAY; INCIDENCE; INFECTION CONTROL; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; MULTILOCUS ENZYME ELECTROPHORESIS; NEISSERIA MENINGITIDIS; NONHUMAN; PHENOTYPE; RELIABILITY; SEROLOGY;

DENMARK; DISEASE OUTBREAKS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGIC STUDIES; HUMANS; LABORATORIES; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS; PHENOTYPE; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES;

EID: 15944414571     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268804003413     Document Type: Article

References (38)

1. Peltola H. Meningococcal disease. An old enemy in Scandinavia. In: Vedros NA, ed. Evolution of meningococcal disease, Vol. I. CRC Press, Inc., 1987: 91-102.
2. Jones DM, Abbott JD. Meningococcal disease in England and Wales. In: Vedros NA, ed. Evolution of meningococcal disease, Vol. I. CRC Press, Inc., 1987: 65-90.
3. Brundage JF, Zollinger WD. Evolution of meningococcal disease epidemiology in the U.S. Army. In: Vedros NA, ed. Evolution of meningococcal disease, Vol. I. CRC Press, Inc., 1987: 5-25.
4. Artenstein MS, Gold R, Zimmerly JG, Wyle FA, Schneider H, Harkins C. Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med 1970; 282: 417-420.
5. Wahdan MH, Rizk F, El-Akkad AM, et al. A controlled field trail of a serogroup A meningococcal polysaccharide vaccine. Bull WHO 1973; 48: 667-673.
6. Mäkelä PH, Käyhty H, Weckström P, Sivonen A, Renkonen OV. Effect of group A meningococcal vaccine in army recruits in Finland. Lancet 1975; i: 883-886.
7. Samuelsson S. Surveillance and prevention of meningococcal disease Denmark 1980-1996 [Thesis]. Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark, 1999.
8. Andersen J, Berthelsen L, Jensen BB, Lind I. Dynamics of the meningococcal carrier state and characteristics of the carrier strains: a longitudinal study within three cohorts of military recruits. Epidemiol Infect 1998; 121: 85-94.
9. Roder BL (ed.). Handbook of culture media. Statens Serum Institut, Copenhagen, Denmark, 1993.
10. Colding H, Lind I. Counterimmunoelectrophoresis in the diagnosis of bacterial meningitis. J Clin Microbiol 1977; 5: 405-409.
11. Weis N, Berthelsen L, Wachmann H, Lind I. The meningococcal antibody test: how useful in the diagnosis of meningococcal disease? Epidemiol Infect 2004. DOI: 10.1017/S0950268804003425.
12. Andersen J, Berthelsen L, Lind I. Measurement of antibodies against meningococcal capsular polysaccharides B and C in enzyme-linked immunosorbent assays towards an improved surveillance of meningococcal disease. Clin Diagn Lab Immunol 1997; 4: 345-351.
13. Weis N, Lind I. Usefulness of the DNA-fingerprinting pattern and the multilocus enzyme electrophoresis profile in the assessment of outbreaks of meningococcal disease. Epidemiol Infect 1996; 116: 103-114.
14. Bygraves JA, Maiden MCJ. Analysis of the clonal relationships between strains of Neisseria meningitidis by pulsed field gel electrophoresis. J Gen Microbiol 1992; 138: 523-531.
15. Jensen ES, Berthelsen L, Lind I, Fussing V, Sørensen HT, Schønheyder HC. Period prevalence and case-fatality rate associated with distinctive clone complexes of Neisseria meningitidis serogroups B and C. Eur J Clin Microbiol Infect Dis 2002; 21: 506-512.
16. Nielsen HE, Koch C, Magnussen P, Lind I. Complement deficiencies in selected groups of patients with meningococcal disease. Scand J Infect Dis 1989; 21: 389-396.
17. Poolman JT, Jonsdottir K, Jones, DM, Lind I, Frøholm LO, Zanen HC. Meningococcal serotypes and serogroup B disease in North-West Europe. Lancet 1986; 2: 555-558.
18. Samuelsson S, Ege P, Berthelsen L, Lind I. An outbreak of serogroup B:15:P1.16 meningococcal disease, Frederiksborg country, Denmark, 1987-9. Epidemiol Infect 1992; 108: 19-30.
19. Rønne T, Berthelsen L, Buhl LH, Lind I. Comparative studies on pharyngeal carriage of Neisseria meningitidis during a localized outbreak of serogroup C meningococcal disease. Scand J Infect Dis 1993; 25: 331-339.
20. Bruun B, Bremmelgaard A. Increased incidence of meningococci of Group A with reduced sensitivity to sulphonamides [in Danish, English Summary]. Ugeskr Laeger 1975; 137: 979-981.
21. Kolmos HJ, Grytter C, Lind I. Meningococcal disease in two siblings - failure of rifampicin chemoprophylaxis [in Danish, English Summary]. Ugeskr Laeger 1987; 149: 3267-3268.
22. Weis N, Lind I. Epidemiological markers in Neisseria meningitidis: an estimate of the performance of genotyping vs phenotyping. Scand J Infect Dis 1998; 30: 69-75.
23. Andersen J, Berthelsen L, Jensen, BB, Lind I. Surveillance of cases of meningococcal disease associated with military recruits studied for meningococcal carriage. Scand J Infect Dis 2000; 31: 527-531.
24. Wandall DA, Samuelsson S. Meningococcal Disease 1999M. EPI-NEWS, Statens Serum Institut, Copenhagen, Denmark, 2000; week 42/43.
25. Nielsen HE, Andersen EA, Andersen J, et al. Diagnostic assessment of haemorrhagic rash and fever. Arch Dis Child 2001; 2: 160-165.
26. Frasch CE. Meningococcal vaccines. Past, present and future. In: Cartwright K, ed. Meningococcal disease. Chichester, UK: John Wiley and Sons Ltd., 1995: 245-283.
27. Poolman JT, Kriz-Kuzemenska P, Ashton F, et al. Serotypes and subtypes of Neisseria meningitidis: results of an international study comparing sensitivities and specificities of monoclonal antibodies. Clin Diagn Lab Immunol 1995; 1: 69-72.
28. Tyski S, Grzybowska W, Lind I. Active surveillance of meningococcal meningitis in Poland. Centr Eur J Publ Health 1998; 6 219-224.
29. Botha P. Penicillin-resistant Neisseria meningitidis in Southern Africa. Lancet 1988; i: 54.
30. Vázquez JA, Enriquez AM, De La Fuente L, Berrón S, Baquero M. Isolation of a strain of beta-lactamase producing Neisseria meningitidis in Spain. Eur J Clin Microbiol Infect Dis 1996; 15: 181-182.
31. Nicolas P, Cavallo JD, Fabre R, Martet G. Standardization of the Neisseria meningitidis antibiogram. Detection of strains that are relatively resistant to penicillin [in French]. Bull WHO 1998; 76: 393-400.
32. Vázquez JA. The resistance of Neisseria meningitidis to the antimicrobial agents: an issue still in evolution. Rev Med Microbiol 2001; 12: 39-45.
33. Tapsall JW, Shultz T, Limnios E, et al. Surveillance of antibiotic resistance in invasive isolates of Neisseria meningitidis in Australia 1994-1999. Pathology 2001; 33: 359-361.
34. Samuelsson S, Hansen ET, Osler M, Jeune B. Prevention of secondary cases of meningococcal disease in Denmark. Epidemiol Infect 2000; 124: 433-440.
35. Weihe P, Mathiassen B, Rasmussen JM, Petersen T, Isager H. An epidemic outbreak of group B meningococcal disease on the Faroe Islands. Scand J Infect Dis 1988; 20: 291-296.
36. Shultz TR, Tapsall JW, White PA, Newton PJ. An invasive isolate of Neisseria meningitidis showing decreased susceptibility to quinolones. Antimicrob Agents Chemother 2000; 44: 1116.
37. Jensen EJ, Schønheyder HC, Lind I, Berthelsen L, Nørgaard B, Sørensen HT. Neisseria meningitidis phenotypic markers and septicaemia, disease progress and case-fatality rate of meningococcal disease: a 20-year population-based historical follow-up study in a Danish county. J. Med Microbiol 2003; 52: 173-179.
38. Samuelsson S, Gustavsen S, Rønne T. Epidemiology of meningococcal disease in Denmark 1980-1988. Scand J Infect Dis 1991; 23: 723-730.